BioSyent (BIO) Agrees to Acquire Oral Science for $25.5M; Closing Expected This Month

BioSyent (BIO) announced the acquisition of Oral Science for an aggregate consideration of $25.5 million, with closing expected to occur in February 2026. The transaction is subject to customary regulatory and due diligence review. Oral Science, a privately held company based in Cambridge, MA, specializes in oral healthcare diagnostics and treatment solutions. The acquisition is intended to expand BioSyent's portfolio in the dental diagnostics segment, enhancing its market position and broadening its product offerings.